Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.8.0.1
Consolidated Statements of Stockholders' Equity - 9 months ended Mar. 31, 2018 - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Jun. 30, 2017 $ 8,527,967 $ 49,230 $ 72,800,699 $ (64,321,962)
Balance (in shares) at Jun. 30, 2017   49,228,640    
Stock-based compensation 4,175,493 $ 0 4,175,493 0
Fair value of warrants issued 760,507 0 760,507 0
Issuance of common stock, net of issuance costs of $60,000 4,440,000 $ 4,500 4,435,500 0
Issuance of common stock, net of issuance costs of $60,000 (in shares)   4,500,000    
Commitment fee for issuance of common stock 0 $ 345 (345) 0
Commitment fee for issuance of common stock(in shares)   344,669    
Net loss for the nine months ended March 31, 2018 (17,371,037) $ 0 0 (17,371,037)
Balance at Mar. 31, 2018 $ 532,930 $ 54,075 $ 82,171,854 $ (81,692,999)
Balance (in shares) at Mar. 31, 2018   54,073,309